Al-Ola Abdallah/LinkedIn
Aug 12, 2025, 16:02
Al-Ola Abdallah: Highlights from 2025 National ICE-T Conference
Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:
“In a conversation with CancerNetwork at the 2025 National Immune Cell Effector Therapy (ICE-T) Conference, Tiba Al Sagheer, PharmD, BCOP, BCACP, Rebecca Gonzalez, PharmD, BCOP, FASTCT, Syeda Saba Kareem Pharm.D BCOP spoke about their presentations on managing adverse effects across different hematologic malignancy populations
See link for the podcast.”
More posts featuring Al-Ola Abdallah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 12, 2025, 16:02
Aug 12, 2025, 15:59
Aug 12, 2025, 15:50
Aug 12, 2025, 15:43
Aug 12, 2025, 15:37
Aug 12, 2025, 15:30
Aug 12, 2025, 15:29
Aug 12, 2025, 15:21